TY - JOUR
T1 - Clinico-Epidemiological Profile and Genetic Characterization of Rotavirus Strains Among Children Aged Under 5 Years Hospitalized with Acute Gastroenteritis in Karnataka, India
AU - Rajani, Hassan Sreenivasa Murthy
AU - Kiran, Namburu
AU - Marri, Harika
AU - Prakash, Wari
AU - Shivanand, Illalu
AU - Shilpa, Cholachagudda
AU - Kamath, Nutan
AU - Rao, Suchetha
AU - Chaudhary, Varsha Sudhir
AU - Machathi, Anupama
AU - Kharat, Namrata
AU - Kannan, Poovarasan
AU - Mahantashetti, Niranjana
AU - Varghese, Tintu
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Dr. K C Chaudhuri Foundation 2025.
PY - 2025
Y1 - 2025
N2 - Objectives: Rotavirus is the most frequent cause of severe acute gastroenteritis (AGE) in children aged under 5 y in India. This study aimed to determine the proportion of rotavirus gastroenteritis in children aged under 5 y admitted with AGE and to characterize the circulating genotypes after implementation of rotavirus vaccination within the Universal Immunization Program (UIP) in Karnataka, India. Methods: This multicenter, cross-sectional observational study included all children aged under 5 y with AGE admitted to four hospitals in Karnataka. Their demographic and clinical characteristics were recorded using a predesigned electronic form. Stool samples were tested for rotavirus using an enzyme-linked immunosorbent assay (ELISA), and all ELISA-positive samples were genotyped using polymerase chain reaction. Results: Of the 433 children enrolled, 405 had a stool sample tested for rotavirus, of which 97 (23.9%) were positive. The prevalence of rotavirus was highest among children aged 12–23 mo (41.2%), followed by infants aged 24–59 mo (26.8%). Among the 97 rotavirus-positive children, the predominant clinical manifestations were vomiting (95.9%), fever (79.4%), and severe to very severe dehydration (87.6%). G3P[8] (54.2%) was the most common genotype, followed by G1P[6] (17.8%) and G2P[4] (11.5%). Conclusions: Of the children admitted with AGE, 23.9% tested positive for rotavirus, with the highest burden in children aged 12–23 mo. The predominant genotypes were G3P[8], G1P[6], and G2P[4]. Ongoing genotypic surveillance is warranted to assess the impact of rotavirus vaccination on the incidence of rotavirus AGE and circulating rotavirus genotypes in the population to inform rotavirus vaccination strategy.
AB - Objectives: Rotavirus is the most frequent cause of severe acute gastroenteritis (AGE) in children aged under 5 y in India. This study aimed to determine the proportion of rotavirus gastroenteritis in children aged under 5 y admitted with AGE and to characterize the circulating genotypes after implementation of rotavirus vaccination within the Universal Immunization Program (UIP) in Karnataka, India. Methods: This multicenter, cross-sectional observational study included all children aged under 5 y with AGE admitted to four hospitals in Karnataka. Their demographic and clinical characteristics were recorded using a predesigned electronic form. Stool samples were tested for rotavirus using an enzyme-linked immunosorbent assay (ELISA), and all ELISA-positive samples were genotyped using polymerase chain reaction. Results: Of the 433 children enrolled, 405 had a stool sample tested for rotavirus, of which 97 (23.9%) were positive. The prevalence of rotavirus was highest among children aged 12–23 mo (41.2%), followed by infants aged 24–59 mo (26.8%). Among the 97 rotavirus-positive children, the predominant clinical manifestations were vomiting (95.9%), fever (79.4%), and severe to very severe dehydration (87.6%). G3P[8] (54.2%) was the most common genotype, followed by G1P[6] (17.8%) and G2P[4] (11.5%). Conclusions: Of the children admitted with AGE, 23.9% tested positive for rotavirus, with the highest burden in children aged 12–23 mo. The predominant genotypes were G3P[8], G1P[6], and G2P[4]. Ongoing genotypic surveillance is warranted to assess the impact of rotavirus vaccination on the incidence of rotavirus AGE and circulating rotavirus genotypes in the population to inform rotavirus vaccination strategy.
UR - https://www.scopus.com/pages/publications/105015516699
UR - https://www.scopus.com/pages/publications/105015516699#tab=citedBy
U2 - 10.1007/s12098-025-05720-6
DO - 10.1007/s12098-025-05720-6
M3 - Article
AN - SCOPUS:105015516699
SN - 0019-5456
JO - Indian Journal of Pediatrics
JF - Indian Journal of Pediatrics
ER -